Kochetkova V A, Mamontov A S, Sokolova I I, Mezhova O M, Morozov A F
Zh Mikrobiol Epidemiol Immunobiol. 1982 Jun(6):91-5.
The method of the complex immunization of patients with esophageal cancer against the main causative agents of purulent infections has been developed. Purified concentrated staphylococcal toxoid and polyvalent corpuscular P. aeruginosa vaccine were used for the immunization of 26 patients. Immunization was carried out in 3 injections (11 patients) and 4 injections (15 patients) made at intervals of 7 days. This resulted in the activation of nonspecific immunity factors (the total bactericidal properties of the blood serum, the phagocytic activity of neutrophils, the increase of the IgG level) and in a considerable increase in the factors of specific protection against staphylococcal and P. aeruginosa infections: the titer of staphylococcal anti-alpha-toxin increased 7- to 11-fold and the titer of antibodies to P. aeruginosa antibodies increased 5- to 6.5-fold. The preoperative vaccination of patients decreased the occurrence of postoperative purulent complications from 71% to 11.5%.
已研发出针对食管癌患者进行针对化脓性感染主要病原体的复合免疫方法。使用纯化浓缩葡萄球菌类毒素和多价铜绿假单胞菌微粒疫苗对26例患者进行免疫。免疫分3针(11例患者)和4针(15例患者)进行,间隔7天注射。这导致非特异性免疫因子(血清总杀菌特性、中性粒细胞吞噬活性、IgG水平升高)被激活,并且针对葡萄球菌和铜绿假单胞菌感染的特异性保护因子大幅增加:葡萄球菌抗α毒素滴度提高了7至11倍,铜绿假单胞菌抗体滴度提高了5至6.5倍。患者术前接种疫苗使术后化脓性并发症的发生率从71%降至11.5%。